With regards to the stockpiling of Tamiflu for an influenza pandemic: (a) how does Canada rank among other G7 countries in terms of the number of antiviral treatments the government has stockpiled or intends to stockpile; (b) how do the steps of the government compare to the actions of other G7 countries in terms of using Tamiflu for prophylaxis and treatment; (c) what is the ethical framework for identifying priority groups during a pandemic, and what priority groups have been identified by the government for prophylaxis and treatment; and (d) what priority age groups in order of ranking for prophylaxis and treatment during an influenza pandemic have been identified?
In the House of Commons on March 12th, 2009. See this statement in context.